Sionna Therapeutics, Inc.
Price Action
Technical Summary
EMERGING TRENDSionna Therapeutics, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 70), indicating performance broadly in line with the market. Earnings contraction of 28% provides fundamental context to the price action. Investors should exercise caution due to high volatility (84% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $41.15 | +5.25% | ABOVE |
| 50 SMA | $38.58 | +12.27% | ABOVE |
| 100 SMA | $39.40 | +9.93% | ABOVE |
| 150 SMA | $38.54 | +12.38% | ABOVE |
| 200 SMA | $34.54 | +25.39% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SION in an uptrend right now?
SION has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is SION overbought or oversold?
SION's RSI (14) is 59. The stock is in neutral territory, neither overbought nor oversold.
Is SION outperforming the market?
SION has a Relative Strength (RS) Rating of 70 out of 99. SION is performing about average compared to the market.
Where is SION in its 52-week range?
SION is trading at $43.31, which is 93% of its 52-week high ($46.46) and 91% above its 52-week low ($11.77).
How volatile is SION?
SION has a Beta of 1.14 and 52-week volatility of 84%. It's more volatile than the S&P 500 - expect bigger swings.